Search - tctmd.com

Displaying 341 - 360 of 1074

Sort: Relevancy | Date

News Conference News ACC 2022

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Todd Neale

April 03, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2022

Tailored Nutrition Advice at the Grocery Store Works: SuperWIN

Caitlin E. Cox

April 03, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

EHR-Based CAD Risk Score Outperforms Pooled Cohort Equations at 1 Year

Yael L. Maxwell

March 22, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Caitlin E. Cox

February 11, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Opinion Editor's Corner

The Biggest News of 2021: TCTMD’s Top 10

Shelley Wood

December 30, 2021

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

Advertisement

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Tailored Nutrition Advice at the Grocery Store Works: SuperWIN

What’s Going to Be Hot at ACC 2022, In Person or Virtual

EHR-Based CAD Risk Score Outperforms Pooled Cohort Equations at 1 Year

More Evidence Links Breast Arterial Calcification and CVD Risk

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

The Biggest News of 2021: TCTMD’s Top 10

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Women Less Likely Than Men to Experience SCD During Sports

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content